123 results
424B3
QNRX
Quoin Pharmaceuticals Ltd
10 May 24
Prospectus supplement
4:10pm
to the consummation of the Merger, the compensation, including salary, office and car allowances and other benefits, due to Dr. Myers and Ms. Carter under … research and development expenses may include:
employee-related expenses, such as salaries, bonuses and benefits, consultant-related expenses, share-based
POS AM
QNRX
Quoin Pharmaceuticals Ltd
29 Mar 24
Prospectus update (post-effective amendment)
4:11pm
to demonstrate that a product candidate’s clinical and other benefits outweigh its safety risks;
such authorities may not agree that the data … false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare.
HIPAA, as amended
8-K
EX-99.1
zxrid6
13 Mar 24
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
4:52pm
424B3
w18kqle7ud16n4 sr1ns
8 Mar 24
Prospectus supplement
4:06pm
424B3
14bdl9dlj54i9u8 9d6
8 Mar 24
Prospectus supplement
4:04pm
8-K
EX-10.1
xtwk8zn11p2xxafnnih4
8 Mar 24
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
4:01pm
8-K
EX-1.1
srd 2eafzr8
8 Mar 24
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
4:01pm
424B4
eopquf
6 Mar 24
Prospectus supplement with pricing info
5:07pm
424B3
olicz ubw0x0xvq3
4 Mar 24
Prospectus supplement
5:27pm
424B3
oql8fnqnduc 5c0un2ce
31 Jan 24
Prospectus supplement
12:00am
8-K
EX-10.1
3ma4xwq 1vsw
30 Jan 24
Entry into a Material Definitive Agreement
4:05pm
424B3
u2kdm zxj
9 Nov 23
Prospectus supplement
5:15pm